DGAP-News: Change in the Supervisory Board of MEDICLIN
DGAP-News: MediClin AG
/ Key word(s): Personnel
Change in the Supervisory Board of MEDICLIN
14.10.2019 / 14:47
The issuer is solely responsible for the content of this announcement.
Offenburg, 14 Oktober, 2019
Change in the Supervisory Board of MEDICLIN
Today, the Chairmann of the Supervisory Board of MEDICLIN Aktiengesellschaft (MEDICLIN), Dr. Ulrich Wandschneider, informed the Management Board and the Supervisory Board that he resigns from his mandate as a member of the Supervisory Board and thus also his chairmanship for personal reasons as of 15 November 2019, taking into account the notice period agreed in the Articles of Association.
Dr. Ulrich Wandschneider was Chairman of the Management Board of MEDICLIN from November 2004 until end of May 2012. Since June 2012, he is a member of the Supervisory Board of the company and chairman of this body.
The Management Board Members of MEDICLIN regret the decision of
Dr. Ulrich Wandschneider and they thank him for the trusting and constructive cooperation.
About MEDICLIN AG (Ticker: MED; WKN: 659 510)
MEDICLIN owns 36 clinics, seven nursing care facilities, two in-home elder care services and ten medical care centres. The Group has about 8,350 beds and a headcount of more than 10,000. With its strong network, MEDICLIN can offer its patients integrated care from the first visit to the doctor to surgery, post-operative rehabilitation and follow-up care at home. Doc-tors, therapists and nurses work together closely to achieve the best results. MEDICLIN plans the care of persons in need in accordance with their individual requirements and personal needs, either at home or in a nursing care facility.
MEDICLIN - A company of the Asklepios Group.
14.10.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
MediClin AG |
|
Okenstraße 27 |
|
77652 Offenburg |
|
Germany |
Phone: |
+49 (0)781 488-326 |
Fax: |
+49 (0)781 488-184 |
E-mail: |
[email protected] |
Internet: |
www.mediclin.de |
ISIN: |
DE0006595101 |
WKN: |
659510 |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
889799 |
|
End of News |
DGAP News Service |
889799 14.10.2019
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
Umsatzerlöse1 |
609,08 |
645,11 |
673,09 |
659,86 |
673,14 |
704,70 |
730,07 |
EBITDA1,2 |
27,01 |
37,35 |
93,58 |
77,50 |
85,22 |
90,92 |
98,73 |
EBITDA-Marge3 |
4,43 |
5,79 |
13,90 |
11,74 |
12,66 |
12,90 |
|
EBIT1,4 |
6,62 |
15,06 |
22,41 |
0,15 |
11,56 |
19,52 |
12,72 |
EBIT-Marge5 |
1,09 |
2,33 |
3,33 |
0,02 |
1,72 |
2,77 |
1,74 |
Jahresüberschuss1 |
3,96 |
7,76 |
9,68 |
-0,04 |
1,49 |
9,72 |
-10,72 |
Netto-Marge6 |
0,65 |
1,20 |
1,44 |
-0,01 |
0,22 |
1,38 |
-1,47 |
Cashflow1,7 |
19,34 |
29,77 |
69,59 |
118,69 |
81,97 |
34,64 |
78,00 |
Ergebnis je Aktie8 |
0,08 |
0,16 |
0,20 |
-0,19 |
0,03 |
0,20 |
-0,23 |
Dividende8 |
0,05 |
0,05 |
0,05 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: PricewaterhouseCoopers
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Mediclin |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
659510 |
2,840 |
Halten |
134,90 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
10,92 |
19,30 |
0,56 |
21,35 |
KBV |
KCV |
KUV |
EV/EBITDA |
0,69 |
1,73 |
0,18 |
1,57 |
Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
06.06.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
02.05.2024 |
31.07.2024 |
04.11.2024 |
26.03.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
10,21% |
4,30% |
3,65% |
-7,79% |
|
|